Neuralstem Reports Last Subject Out in Phase 2 Trial of NSI-189 for Major Depressive Disorder May 17, 2017
Neuralstem Reports First Quarter 2017 Fiscal Results Provides Clinical and Business Update May 10, 2017
Neuralstem Announces Publication of NSI-566 Data in a Rodent Model of Traumatic Brain Injury Mar 9, 2017